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planning objectives, drawn from a Gaussian distribution with 
the base plan objective as mean and a pre-defined standard 
deviation, were automatically generated using worst-case 
scenario optimisation. Plans were evaluated on robustness by 
selecting the single-worst of 12 simulated perturbation 
scenarios based on density (3%) and position (8 mm in all 
directions) errors. For the plans fulfilling all minimal 
requirements after robustness evaluation, the PF was 
estimated based on the dominating plans for which one 
objective of interest cannot be improved without 
deteriorating other evaluation objectives of interest. To 
iteratively improve the PF estimate, a new base plan was 
automatically created using average planning objectives of 
dominating plans for a next iteration. After 5 iterations with 
20 plans each, dominating plans were determined to form the 
2D PF. Per patient, PFs based on different beam set-ups were 
compared by investigating trade-off differences between 
objectives of interest. 
 
Results: In total, 825 robustly optimised IMPT plans were 
automatically created and evaluated within 550 hours. Per 
derived PF, on average 25 plans (range, 11–45) did not fulfil 
all requirements and 15 dominating plans (range, 13–18) were 
found. The figure shows an example of dominating plans that 
form the PF (A) and PFs based on different beam set-ups used 
for comparison (B). For 2 out of 3 patients, PF comparison 
indicated a better trade-off between CTV D99% and rectum 
V30Gy for robust IMPT plans using 4 beams. 
 
 
Conclusions: A novel method to iteratively determine PFs 
based on robustly optimised IMPT plans including robustness 
evaluation was successfully scripted in RayStation. We 
demonstrated the feasibility of beam set-up comparison using 
PFs for proton therapy planning in cervical cancer.  
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Purpose/Objective: Xerostomia is the most frequently 
reported side effect of radiotherapy in head and neck cancer 
and has a major impact on quality of life. Current 
measurements of xerostomia are either subjective or 
unpleasant for the patient. We hypothesize that volume and 
density of the parotid and submandibular glands, which can 
be objectively determined from CT-scans, are related to 
their function and can therefore be used as image biomarkers 
for xerostomia. To test this hypothesis, we investigated the 
association of these image features with patient-rated 
xerostomia. 
Materials and Methods: This prospective study included 110 
patients with head and neck cancer who were treated with 
radiotherapy. Patient-rated xerostomia was scored on a 4-
point Likert scale using the EORTC QLQ-H&N35 questionnaire 
12 weeks after treatment start (Xer12wk) and 6 months after 
treatment (Xer6m). In addition, CT-scans were made at 
baseline and 12 weeks after treatment. The CT density (in 
HU), volume (in cm3) and their change between both CT-
scans were calculated for the parotid and submandibular 
glands. Associations with Xer12wk and Xer6m were calculated 
using univariable and multivariable linear regression and 
Pearson correlation (r). 
Results: In the univariable analysis a statistically significant 
relation was found between Xer12wk and change in volume of 
the parotid glands and change in density of the 
submandibular glands between the CT-scans at baseline and 
12 weeks after treatment (Table 1). Furthermore, a 
statistically significant relation was found between Xer6m and 
change in and density of the parotid glands and change in 
density of the submandibular glands. 
 
 
 
At baseline, a high density of the parotid (β = 0.004, p = 
0.03, r = 0.22) and submandibular glands (β = 0.004, p = 0.05, 
r = 0.20) were predictive for Xer6m. No baseline features were 
significantly associated with Xer12wk. 
In the multivariable model the change in volume of the 
parotid glands and change in density of the submandibular 
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glands were independently associated with Xer6m, with a 
correlation coefficient of 0.454 between the model 
predictions and Xer6m. No multivariable model with multiple 
significant independent predictors was found for Xer12wk. 
A significant correlation between Xer6m and Xer12wk was found 
with a correlation coefficient of 0.627 
Conclusions: The volume and density of the parotid glands 
and the density of the submandibular glands are associated 
with xerostomia after radiotherapy. The changes of these CT 
image features over the course of treatment are more 
strongly related to xerostomia than the instantaneous feature 
values at baseline. Moreover, the feature changes in the first 
12 weeks after start of treatment are equally or even more 
strongly related to xerostomia at 6 month than at 12 weeks. 
These associations suggest that, even early after treatment, 
the CT image feature changes may be used as objective 
biomarkers of the development of xerostomia. 
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Purpose/Objective: Hematologic toxicity (HT) is an 
important side-effect of whole pelvis intensity-modulated 
radiotherapy (WP-IMRT), but association between radiation 
dose and HT remains unclear when concurrent chemotherapy 
is not prescribed. The aim of this study was to identify 
clinical and dosimetric predictors of HT in a cohort of chemo-
naÏf patients treated with WPRT. 
Materials and Methods: The first 121 patients enrolled in a 
prospective observational study, treated with adjuvant 
(n=72) or salvage (n=49) WP-IMRT in a single Institute were 
available (static field IMRT: 19; VMAT/Rapidarc:57; Helical 
Tomotherapy:45). Pelvic bones, used as a surrogate for pelvic 
bone marrow (BM), were contoured according to Mell et al 
[IJROBP 2006] and divided in four subvolumes: ilium (IL), 
lumbosacral spine (LS), lower pelvis (LP) and whole pelvis 
(WP). The volume of each BM region receiving 3, 5, 10, 20, 
30, 40 and 50 Gy (V3-50) was recovered. 
Absolute values of lymphocytes (ALC), white blood cell (WBC) 
and neutrophils (N) were prospectively collected before 
WPRT, at half WPRT, at end WPRT, at 3m and at 12 months 
after WPRT. HT was graded according to CTCAE v. 3.0: Grade 
3 (G3) and Grade 1 (G1) events were considered as end-
points for acute (nadir value) and late HT respectively. Uni- 
and backward multi-variable logistic regression was 
performed to assess correlation between clinical/DVH 
parameters and HT. A previously introduced method based on 
DVH differences between patients with/without HT was used 
to select the most discriminative DVH parameters.  
Results: The nadir of WBC and N (median values= 65% and 
74% of baseline respectively) was found at half-therapy while 
it was at the end of RT for ALC (median= 30% of baseline). 
No patients showed acute G3 neither late G1 WBC and N 
toxicities. Interestingly, the mean value of ALC at 1 year was 
54% of baseline: 28 acute G3 and 14 late G1 lymphopenias 
were found. Then, the analysis was restricted to ALC at the 
end of therapy (ALCend) and at 12 months (ALC12m). 
At univariate analysis, a lower baseline ALC (ALCbase) was 
correlated with G3 ALCend and G1 ALC12m (p=0.003 and 
p<0.001, respectively). Concerning dosimetric parameters, 
IL-V30/IL-V40 and WP-V40 were correlated with acute G3 
ALCend and late G1 ALC12m (p=0.003). The resulting model 
for ALCend included ALCbase and WP-V40 (AUC =0.73); the 
model for ALC12m included ALCbase and IL-V40 (AUC= 0.82). 
Best cut-off values (assessed by ROC) discriminating patients 
with/without lymphopenia were: ALCbase ≤1830 x 10(9)/L 
and WP-V40 >599.4 cc (G3 ALCend); ALCbase ≤1780 x 10(9)/L 
and IL-V40>94.6 cc (G1 ALC12m) (Fig-1). 
 
 
 
Conclusions: Two-variable models including ALCbase and 
DVH parameters of pelvic BM may predict acute G3 and late 
G1 lymphopenia after WP-IMRT in post-prostatectomy RT. 
The model could be used to reduce HT by constraining BM. 
Further validation on a larger population is ongoing.  
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Purpose/Objective: A final accuracy of positioning < 2 mm is 
the recommended tolerance level for image-guided 
radiotherapy (IGRT) for spine stereotactic radiosurgery (SRS) 
in RTOG 0631. However, the tolerance level for rotation is 
not specified. This study investigated experimentally the 
effect of rotational setup errors on dose distribution for spine 
SRS. 
Materials and Methods: The contour definitions and 
treatment planning were as per RTOG 0631. A 16-Gy dose was 
prescribed in a single fraction by step-and-shoot intensity-
modulated radiation therapy (IMRT) using seven coplanar 
beams with the Vero4DRT (Mitsubishi Heavy Industries, Ltd., 
Hiroshima, Japan, and Brainlab AG, Feldkirchen, Germany). 
An isocenter was placed inside the vertebral body. Setup 
error patterns were categorized into three groups. Only 
translational errors were generated for Group A, with the 
translational errors measuring +1, +2, +3, and +5 mm in the 
lateral (LAT), longitudinal (LNG), and vertical (VRT) 
directions, respectively. Only rotational errors were 
generated for Group B, and measured +1°, +2°, +3°, and +5° 
in terms of the tilt or roll angle. Combinations of 
translational and rotational errors occurred in Group C. 
Translational errors of 0 to 2 mm were generated in each 
direction and rotational errors of ±1° or ±2° in each 
direction. Data were acquired with a Delta4 phantom 
(ScandiDos, Uppsala, Sweden) and setup errors were 
generated with HexaMotion (ScandiDos, Uppsala, Sweden). 
